📰 Assertio Therapeutics News
Page 4 - Assertio Therapeutics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Assertio Therapeutics. Real-time updates on events, politics, business and more.
January 24, 2022
24.01.2022 - EQS-Ad-hoc: RELIEF THERAPEUTICS Holding AG / Key word(s): Patent Relief Therapeutics Wholly Owned Subsidiary, APR Applied Pharma Research, Receives Notice of Allowance of Key U.S. Patent Application Covering Ready to Use Diclofenac Stick Packs ... Seite 1
January 24, 2022
/PRNewswire/ -- According to Coherent Market Insights, the global opioids market is estimated to be valued at US$ 42,429 million in 2021 and is expected to...
January 13, 2022
DUBAI, United Arab Emirates, Jan. 13, 2022 (GLOBE NEWSWIRE) -- The latest study by Future Market Insight (FMI) provides insights into the governing...
December 16, 2021
/PRNewswire/ -- As per a thorough research by FMI, the Global Analgesics Market is poised to top US$ 77.3 Bn in 2021. Increasing demand for opioid drugs for...
December 6, 2021
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that "embecta" [pronounced...
October 27, 2021
/PRNewswire/ -- As per an exhaustive study by FMI, the Global Opioid Analgesics Market is anticipated to reach US$ 65.8 billion by 2031. In response to surging...
October 27, 2021
/PRNewswire/ -- As per an exhaustive study by FMI, the Global Opioid Analgesics Market is anticipated to reach US$ 65.8 billion by 2031. In response to surging...
October 27, 2021
Future Market Insights' (FMI's) latest survey provides an unbiased analysis of the opioid analgesics market, presenting historical demand data (2016-2020) and forecast statistics for the period
June 29, 2021
NEW YORK and BASEL, Switzerland, June 28, 2021 /PRNewswire/ -- Aruvant Sciences, a private company focused on developing gene therapies for rare diseases, today announced the appointment of Stanley J. Musial as chief financial officer (CFO) effective immediately. Mr. Musial brings over twenty-five years of experience building corporate value through operational execution, financial strategy and capital fundraising. "Stans expertise in managing financials and raising capital at both private ...
April 23, 2021
Pharmaceutical firms may have engaged in “bad faith” by failing to inform a judge overseeing a patent settlement in 2012 about an allegedly anticompetitive side deal, a federal judge said Thursday. SAN FRANCISCO (CN) — In a class action seeking billions of dollars from pharmaceutical firms accused of plotting to jack up the price of an essential diabetes drug, a federal judge said Thursday drug companies may have a hard time justifying the price increase to a jury. “I don’t think you�...